Goodwin Advises Delix Therapeutics on Its $100 Million Series C Financing
November 09, 2026
November 09, 2026
BOSTON, Massachusetts, Nov. 9 [Category: BizLaw/Legal] -- Goodwin, a law firm, posted the following news release:
* * *
Goodwin Advises Delix Therapeutics on Its $100 Million Series C Financing
*
The Life Sciences team advised Delix Therapeutics on its oversubscribed $100 million Series C financing. The round was led by Johnson & Johnson through its corporate venture capital organization, Johnson & Johnson Innovation -- JJDC, Inc., and . . .
* * *
Goodwin Advises Delix Therapeutics on Its $100 Million Series C Financing
*
The Life Sciences team advised Delix Therapeutics on its oversubscribed $100 million Series C financing. The round was led by Johnson & Johnson through its corporate venture capital organization, Johnson & Johnson Innovation -- JJDC, Inc., and . . .
